基本信息
views: 148
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
许大康,医学博士,研究员,博士生导师,曾获得澳大利亚国家卫生研究项目及健康研究基金的项目资助(NHMRC grant)多项。国家自然科学基金面上项目五项(12,14,16,18,20年)。担任国际著名期刊: Frontiers in Oncology, Clinical and Experimental Pharmacology and Physiology (CEPP) 的副主编。已发表SCI论文70余篇,其中第一及通讯作者占20篇以上,多篇论文发表在国际重要核心刊物如 Immunity, EMBO J和Nature Immunology , Nature communication , Proc. NatI. Acad. Sci(PNAS), Cancer Res等学术期刊上。作为主编,于2017年在Springer Nature 出版社出版了免疫学专著《Regulation of Inflammatory Signaling in Health and Disease》。
Research Interests
Papers共 104 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Maimaitiaili Yimiti,Xuefeng Fei,Hao Yang,Xiaobao Yang, Shuhui Li, Huxidanmu Tuoheniyazi, Danping Liu,Junrui Ma, Jialing Xie,Juanjuan Zheng,Zhen Song,Qingtian Li,
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGYno. 6 (2024): e13866-e13866
CANCERSno. 7 (2024): 1434
Annals of the rheumatic diseasesno. 5 (2024): 576-588
Hao Yang,Yuzhang Du,Xuefeng Fei,Shu Huang,Maimaitiaili Yimiti,Xiaobao Yang,Junrui Ma, Shuhui Li, Huxidanmu Tuoheniyazi,Yanan Zhao,Zhidong Gu,Dakang Xu
Nature communicationsno. 1 (2023): 8465-16
FRONTIERS IN IMMUNOLOGY (2023): 1158964
crossref(2023)
Load More
Author Statistics
#Papers: 103
#Citation: 4607
H-Index: 36
G-Index: 67
Sociability: 6
Diversity: 0
Activity: 1
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn